We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+8.21%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$214M
AUM Growth
+$9.71M
Cap. Flow
-$616K
Cap. Flow %
-0.29%
Top 10 Hldgs %
6.68%
Holding
490
New
42
Increased
186
Reduced
165
Closed
36

Top Buys

Rank Stock Value
1
OCCI
OFS Credit Co
OCCI
+$2.05M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$1.92M
3
ECC
Eagle Point Credit Company
ECC
+$1.26M
4
APP icon
Applovin
APP
+$1.04M
5
CEG icon
Constellation Energy
CEG
+$1.01M

Top Sells

Rank Stock Value
1
OXLC
Oxford Lane Capital
OXLC
+$1.49M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.06M
3
GEN icon
Gen Digital
GEN
+$1.01M
4
ADBE icon
Adobe
ADBE
+$989K
5
STE icon
Steris
STE
+$907K

Sector Composition

Rank Sector Weight
1 Financials 28.16%
2 Healthcare 18.37%
3 Technology 14.33%
4 Industrials 8.16%
5 Consumer Discretionary 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRGX
376
DELISTED
CARGO Therapeutics
CRGX
$99K 0.05%
5,368
+99
+2% +$1.77K
JANX icon
377
Janux Therapeutics
JANX
$898M
$98.9K 0.05%
2,178
+41
+2% +$1.78K
IMVT icon
378
Immunovant
IMVT
$7.79B
$98.7K 0.05%
3,462
+59
+2% +$1.74K
DYN icon
379
Dyne Therapeutics
DYN
$4.14B
$98.3K 0.05%
2,736
+49
+2% +$1.95K
TERN
380
DELISTED
Terns Pharmaceuticals
TERN
$96.3K 0.05%
11,550
+206
+2% +$1.7K
SVRA icon
381
Savara
SVRA
$1.07B
$96.3K 0.05%
22,701
+404
+2% +$1.78K
XENE icon
382
Xenon Pharmaceuticals
XENE
$6.19B
$95.5K 0.04%
2,425
+45
+2% +$1.81K
EXAI
383
DELISTED
Exscientia Plc American Depositary Shares
EXAI
$94.5K 0.04%
19,359
+341
+2% +$1.78K
PHVS icon
384
Pharvaris
PHVS
$2.28B
$94.2K 0.04%
5,089
+88
+2% +$1.61K
DNTH icon
385
Dianthus Therapeutics
DNTH
$5.56B
$93.7K 0.04%
3,422
+64
+2% +$1.78K
CYTK icon
386
Cytokinetics
CYTK
$10.7B
$92.2K 0.04%
1,747
+30
+2% +$1.67K
NGNE icon
387
Neurogene
NGNE
$645M
$92.1K 0.04%
2,194
+38
+2% +$1.47K
ARQT icon
388
Arcutis Biotherapeutics
ARQT
$3.5B
$91.8K 0.04%
9,867
+175
+2% +$1.73K
ANNX icon
389
Annexon
ANNX
$790M
$90.8K 0.04%
15,339
+276
+2% +$1.64K
CELC icon
390
Celcuity
CELC
$3.93B
$89.5K 0.04%
6,006
+105
+2% +$1.73K
BEAM icon
391
Beam Therapeutics
BEAM
$2.66B
$89.5K 0.04%
3,653
+66
+2% +$1.71K
OLMA icon
392
Olema Pharmaceuticals
OLMA
$997M
$88.3K 0.04%
7,394
+129
+2% +$1.65K
MLYS icon
393
Mineralys Therapeutics
MLYS
$2.34B
$88K 0.04%
7,267
+133
+2% +$1.61K
ALEC icon
394
Alector
ALEC
$170M
$87.1K 0.04%
18,697
+335
+2% +$1.8K
XNCR icon
395
Xencor
XNCR
$1.44B
$86.9K 0.04%
4,323
+75
+2% +$1.41K
QURE icon
396
uniQure
QURE
$2.76B
$86.6K 0.04%
17,556
+313
+2% +$2.04K
BLTE
397
Belite Bio
BLTE
$6.09B
$86.4K 0.04%
1,843
+36
+2% +$1.75K
PLRX icon
398
Pliant Therapeutics
PLRX
$66.3M
$86.3K 0.04%
7,697
+134
+2% +$1.68K
CLDX icon
399
Celldex Therapeutics
CLDX
$2.81B
$86K 0.04%
2,529
+44
+2% +$1.68K
ARVN icon
400
Arvinas
ARVN
$526M
$85.9K 0.04%
3,486
+63
+2% +$1.65K
14 15
16
17 18

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
RC
Roubaix Capital Denver, Colorado $214M AUM 32.43% 1-Year Est. Return

Virtus ETF Advisers's Q3 2024 Portfolio in Review

As of Q3 2024, Virtus ETF Advisers held 490 positions worth $214M, up 4.8% from $204M the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.

Virtus ETF Advisers's Q3 2024 filing shows 42 new, 186 increased, 165 reduced and 36 closed positions. Its largest new stake was OFS Credit Co: 278,579 shares worth $2.06M. The largest sale was Oxford Lane Capital, an estimated $1.49M.

By sector, the portfolio is most concentrated in Financials at 28% of assets, up from 27% a quarter earlier, followed by Healthcare and Technology.

  • Virtus ETF Advisers's largest Q3 2024 buy was OFS Credit Co: 278,579 shares worth $2.06M.
  • Virtus ETF Advisers added most to Public Storage in Q3 2024, an estimated $927K increase.
  • Virtus ETF Advisers's biggest Q3 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.06M.
  • Virtus ETF Advisers fully exited Oxford Lane Capital in Q3 2024, selling an estimated $1.49M.
  • Virtus ETF Advisers's ten largest holdings make up 6.7% of its $214M portfolio in Q3 2024.
  • Virtus ETF Advisers opened 42 new positions and closed 36 in Q3 2024.
  • Virtus ETF Advisers's portfolio value rose 4.8% quarter-over-quarter to $214M.

Based on Virtus ETF Advisers's 13F filing for Q3 2024, filed 14 Nov 2024.